A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC.

Saved in:
Bibliographic Details
Title: A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC.
Authors: Wu H; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Liu C; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Yuan Q; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Qiao Y; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Ding Y; Department of Pathophysiology, Shaoxing People Hospital, Shaoxing, China., Duan L; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Li W; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Zhang M; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Zhang X; The Affiliated Cancer Hospital, Zhengzhou University, Zhengzhou, China., Jiang Y; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Lu J; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Dong Z; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China., Wang T; Telethon Kids Institute, University of Western Australia, Perth, Australia.; The College of Nursing and Health, Zhengzhou University, Zhengzhou, China., Liu K; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, China., Zhao J; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, China.
Source: Oncoimmunology [Oncoimmunology] 2023 Nov 27; Vol. 12 (1), pp. 2282250. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38126034
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wu+H%22">Wu H</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Liu+C%22">Liu C</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Yuan+Q%22">Yuan Q</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Qiao+Y%22">Qiao Y</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Ding+Y%22">Ding Y</searchLink>; Department of Pathophysiology, Shaoxing People Hospital, Shaoxing, China.<br /><searchLink fieldCode="AU" term="%22Duan+L%22">Duan L</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+W%22">Li W</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+M%22">Zhang M</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; The Affiliated Cancer Hospital, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Jiang+Y%22">Jiang Y</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Lu+J%22">Lu J</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Dong+Z%22">Dong Z</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Wang+T%22">Wang T</searchLink>; Telethon Kids Institute, University of Western Australia, Perth, Australia.; The College of Nursing and Health, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Liu+K%22">Liu K</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhao+J%22">Zhao J</searchLink>; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, China.; Henan Provincial Cooperative Innovation Center for Cancer Chemo- prevention, Zhengzhou, China.; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2023 Nov 27; Vol. 12 (1), pp. 2282250. <i>Date of Electronic Publication: </i>2023 Nov 27 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2162-402X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38126034
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2023.2282250
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2282250
    Titles:
      – TitleFull: A novel Fc-enhanced humanized monoclonal antibody targeting B7-H3 suppresses the growth of ESCC.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wu H
      – PersonEntity:
          Name:
            NameFull: Liu C
      – PersonEntity:
          Name:
            NameFull: Yuan Q
      – PersonEntity:
          Name:
            NameFull: Qiao Y
      – PersonEntity:
          Name:
            NameFull: Ding Y
      – PersonEntity:
          Name:
            NameFull: Duan L
      – PersonEntity:
          Name:
            NameFull: Li W
      – PersonEntity:
          Name:
            NameFull: Zhang M
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Jiang Y
      – PersonEntity:
          Name:
            NameFull: Lu J
      – PersonEntity:
          Name:
            NameFull: Dong Z
      – PersonEntity:
          Name:
            NameFull: Wang T
      – PersonEntity:
          Name:
            NameFull: Liu K
      – PersonEntity:
          Name:
            NameFull: Zhao J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 11
              Text: 2023 Nov 27
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2162-402X
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1